VANCOUVER, BC, Aug. 22, 2024 /PRNewswire/ – Wheaton Precious Metals™ Corp. (“Wheaton” or the “Company”) is pleased to announce that it will host an Investor Day webcast on Tuesday, September 24, 2024, starting at 9:00am Eastern Time. Speakers will include Randy Smallwood, President and Chief Executive Officer, as well as the Wheaton Executive team. In
A-Mark Precious Metals (NASDAQ: AMRK) has scheduled its fiscal fourth quarter and full year 2024 earnings call for Thursday, August 29, at 4:30 p.m. ET. The company, a leading integrated precious metals platform, will release its financial results for the period ended June 30, 2024, prior to the call. Management
InCred Equities Nifty 50 Overview: •\u0009Resistance Levels: 24,622, 24,650, 24,694 (based on pivot points) •\u0009Support Levels: 24,534, 24,507, 24,462 (based on pivot points) •\u0009Market Sentiment: As long as Nifty 50 sustains above 24,500-24,550, it is likely to move towards 24,700-24,800. A fall below the 24,400-24,300 range could trigger further downside. •\u0009Candlestick Pattern: Despite forming a
Jaguar Health (NASDAQ:JAGX) announced that Hong Kong’s Intellectual Property Department has issued a new patent to Napo Pharmaceuticals, a Jaguar family company, for methods of treating short bowel syndrome (SBS), bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal using crofelemer. This patent strengthens Jaguar’s IP
INDIA 1)India’s retail inflation in July dropped to 3.54%, marking a near five-year low as food prices eased, government data showed. The actual figure fell below the Reserve Bank of India’s 4% target, primarily due to a high-base effect from last year. 2)Food prices, which constitute nearly half of the retail inflation basket, saw a
Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) held its Annual General Meeting of Shareholders on August 15, 2024. The meeting saw a strong shareholder turnout, with 88.37% of the company’s total issued and outstanding shares represented. Shareholders approved all management resolutions, including: Fixing the number of directors at seven
Jefferies On HPCL Underperform Call, Target Rs 315 Q1 Showed Weak Set Of Numbers With EBITDA Down 56% QoQ But Was 21% Ahead Of Est EBITDA Came Higher Than Est On Higher Marketing Inventory Gains While Refining Was Weaker Co Remains Vulnerable With No Change To Retail Prices Post Elections Refining Margin Should Remain Rangebound,
TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications
EDINBURGH, Scotland, Aug. 28, 2024 /PRNewswire/ — TC BioPharm (Holdings) PLC (“TC BioPharm” or the “Company”) (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has received a patent grant from European Patent Office (EPO) covering the use of modified gamma delta